EHA 2026

June 11-14, 2026
Stockholm, Sweden

31st Congress of the European Hematology Society

Explore more Hematology congress materials

Results(1)

Hematology

CPX-351 versus Standard of Care as Bridging to AlloHCT in Patients with Higher-Risk Myelodysplastic Neoplasms or Oligoblastic Acute Myeloid Leukemia: Results of the Randomized Phase 2 PALOMA Study

Author(s): Uwe Platzbecker, Martina Crysandt, Martin Kaufmann et al.

Disclaimer

This AI model is continuing to learn and its responses are based on learned data patterns. It should not replace professional judgment. Please verify the information before use, and feedback is welcome to improve its accuracy.

Please do not include personal or confidential information in your searches. For information on how to report an adverse event or product complaint for a Jazz product, please visit: https://www.jazzpharma.com/medicines/drug-safety/.